Andrews JM - Search Results

1

Infliximab-related weight gain in inflammatory bowel disease: associations and financial impacts.

Kaazan P, Tan Z, Bednarz J, Hughes J, Grafton R, Andrews JM. Kaazan P, et al. Among authors: andrews jm. Intern Med J. 2020 Sep;50(9):1134-1138. doi: 10.1111/imj.14987. Intern Med J. 2020. PMID: 32929820

2

Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review.

Mikocka-Walus AA, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Mikocka-Walus AA, et al. Among authors: andrews jm. Inflamm Bowel Dis. 2007 Feb;13(2):225-34. doi: 10.1002/ibd.20062. Inflamm Bowel Dis. 2007. PMID: 17206706 Review.

3

Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?

Andrews JM, Travis SP, Gibson PR, Gasche C. Andrews JM, et al. Aliment Pharmacol Ther. 2009 Mar 1;29(5):459-69. doi: 10.1111/j.1365-2036.2008.03915.x. Epub 2008 Dec 11. Aliment Pharmacol Ther. 2009. PMID: 19077129 Review.

4

Un-promoted issues in inflammatory bowel disease: opportunities to optimize care.

Andrews JM, Mountifield RE, Van Langenberg DR, Bampton PA, Holtmann GJ. Andrews JM, et al. Intern Med J. 2010 Mar;40(3):173-82. doi: 10.1111/j.1445-5994.2009.02110.x. Epub 2009 Oct 22. Intern Med J. 2010. PMID: 19849744 Review.

5

Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia.

Connell W, Andrews JM, Brown S, Sparrow M. Connell W, et al. Among authors: andrews jm. Intern Med J. 2010 Feb;40(2):139-49. doi: 10.1111/j.1445-5994.2009.02122.x. Intern Med J. 2010. PMID: 20446955

6

Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change.

van Langenberg DR, Lange K, Hetzel DJ, Holtmann GJ, Andrews JM. van Langenberg DR, et al. Among authors: andrews jm. J Gastroenterol Hepatol. 2010 Jul;25(7):1250-8. doi: 10.1111/j.1440-1746.2010.06302.x. J Gastroenterol Hepatol. 2010. PMID: 20594252

7

Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit.

Gapasin J, Van Langenberg DR, Holtmann G, Hetzel DJ, Andrews JM. Gapasin J, et al. Among authors: andrews jm. Intern Med J. 2012 May;42(5):e84-8. doi: 10.1111/j.1445-5994.2010.02328.x. Epub 2010 Jul 30. Intern Med J. 2012. PMID: 20681962

8

The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience.

van Langenberg DR, Simon SB, Holtmann GJ, Andrews JM. van Langenberg DR, et al. Among authors: andrews jm. J Crohns Colitis. 2010 Oct;4(4):413-21. doi: 10.1016/j.crohns.2010.01.004. Epub 2010 Feb 12. J Crohns Colitis. 2010. PMID: 21122537

9

General practitioners' knowledge of and attitudes to inflammatory bowel disease.

Tan M, Holloway RH, Lange K, Andrews JM. Tan M, et al. Among authors: andrews jm. Intern Med J. 2012 Jul;42(7):801-7. doi: 10.1111/j.1445-5994.2011.02586.x. Intern Med J. 2012. PMID: 21883783

10

An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementation.

Mikocka-Walus AA, Turnbull D, Holtmann G, Andrews JM. Mikocka-Walus AA, et al. Among authors: andrews jm. Inflamm Bowel Dis. 2012 Aug;18(8):1573-81. doi: 10.1002/ibd.22850. Epub 2011 Dec 16. Inflamm Bowel Dis. 2012. PMID: 22179943 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

646 results

Search Page

Filters